NELSON SONJA (Chief Financial Officer) sold 8.9% of their position (12.78K shares) of AMBRX BIOPHARMA, INC. on the open market
Open‑market sale worth $125.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/31/2023ACC: 0000950170-23-056944
Officer· Chief Financial Officer
Since Oct 2023
-12.78K
Net shares
Net seller
$125.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
12.78K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−12.78K
Price / share
$9.82
Trade value
$125.48K
% of position
8.9%
10/27/2023
142.86K→130.08K
Total
Net shares
−12.78K
Net value
-$125.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/27/2023 | S · Sale | −12.78K | $9.82 | $125.48K | 8.9% | 142.86K | 130.08K |
| Total | −12.78K | -$125.48K | ||||||
Derivative Transactions0
No derivative transactions reported